Pfizer Inc. reports $62.58 billion revenue for fiscal year ended December 31, 2025, down 1.6%

ยท PFE

Pfizer Inc. reported revenue of $62.58 billion for the year ended December 31, 2025, a decrease of 1.6% from the previous year ($63.63 billion).

For the same period it posted net income of $7.77 billion, down 3.2%, or $1.36 per diluted share (1.41 a year earlier).

That is a net margin of 12.4%.

On Sanad's AAOIFI Standard 21 screen, Pfizer Inc. is currently not compliant: interest-bearing debt is 38.6% of market capitalisation (limit 30%), and impure income is 1% of revenue (limit 5%).

Source: 10-K filed with the U.S. Securities and Exchange Commission on February 26, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.

More Pfizer Inc. news